about
Phenylketonuria patients' and their parents' acceptance of the disease: multi-centre study.Phenylketonuria patients' and their parents' knowledge and attitudes to the daily diet - multi-centre study.Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome.Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC.Peripheral blood T lymphocyte subsets in children with congenital asplenia.Vitamin D deficiency in children with recurrent respiratory infections, with or without immunoglobulin deficiency.Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome.Impact of lipophilic antioxidants and level of antibodies against oxidized low-density lipoprotein in Polish children with phenylketonuria.Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children.Whey Protein Concentrate WPC-80 Improves Antioxidant Defense Systems in the Salivary Glands of 14-Month Wistar Rats.The effect of C-terminal fragment of ANF-ANF(24-28)OH on the cardiovascular system in ratThe interaction of ANF and C-terminal fragment ANF (24-28)OH with agonist and antagonist of the beta-adrenergic receptor in the cardiovascular system in ratsThe incidence of some civilization diseases in families of children with food allergy/intoleranceApplication of derivative spectrophotometry for determination of coenzyme Q10 in pharmaceuticals and plasmaHPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasmaChronic rhinosinusitis in primary antibody immunodeficient patientsSystemic Redox Imbalance in Patients with Chronic Granulomatous Disease
P50
Q37341947-D408BB82-FB6D-4631-B986-9CABD497E834Q38616652-7E690F74-F3EF-4972-8F28-860BAEDC755BQ39072923-1C849050-416E-4D45-9D67-224BB61B59B0Q40307695-40735D35-BA0C-4FF0-8A49-486A87D890B5Q41053811-7B218CB9-B382-46A9-A285-59AF3D8D0C5AQ43252991-82923463-7225-4FBA-BF24-171F0A2ABCF4Q46847577-89648530-DC15-4D75-AE1B-07AE5531BB95Q47714528-151AC56B-D3C7-47CF-9DB0-1000496C9540Q49874463-22FDF1BE-8020-4E03-8464-754157F4C0A6Q51855018-14A03A4B-6AC4-499F-855C-ED32BE4FECFEQ51953457-6D94E3C2-48DC-4ECD-A429-401F1A32B154Q55515283-91134427-4F6D-4D95-852A-73FE99201A70Q72800711-0A2F6693-FC1C-4279-BF48-473A37CEE648Q72800716-0E19DB16-30A3-4FEC-8935-EBB8E0017169Q75314919-3AF79553-6097-4078-A639-324EA9A002C7Q77506328-00DC1F13-C036-49E3-8E9A-625233FC2E60Q83963226-97D9B1B6-80C8-4E21-873D-1993003B4E7CQ83993833-1946EB1F-405A-428D-8760-97F93B718685Q94591152-91098349-8E25-451C-ACE3-3AB13DC0D1B6
P50
description
researcher
@en
wetenschapper
@nl
name
B Mikoluc
@en
B Mikoluc
@nl
type
label
B Mikoluc
@en
B Mikoluc
@nl
prefLabel
B Mikoluc
@en
B Mikoluc
@nl
P106
P31
P496
0000-0002-8284-6426